source
- Veradermics reports first positive efficacy data for oral minoxidil in women with pattern hair lossVeradermics announced that its oral formulation of minoxidil demonstrated positive efficacy in a mid‑stage trial involving women with pattern hair loss. The results mark the company's first effica…
- AstraZeneca to acquire worldwide rights to Dizal's lung cancer drug Zegfrovy for $600 millionAstraZeneca announced it will pay $600 million upfront to Dizal Pharmaceutical for the worldwide development and sales rights to the lung cancer drug Zegfrovy. The agreement gives AstraZeneca full…